Stock Analysis on Net
Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

デュポンの分析: ROE、ROA、純利益率の内訳 
四半期データ

Microsoft Excel

ROE分解では、純利益を株主資本で割ったものを構成比率の積として表します。

ROEを2つのコンポーネントに分解

Vertex Pharmaceuticals Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = ROA × 財務レバレッジ比率
2024/12/31 -3.26% = -2.38% × 1.37
2024/09/30 -3.07% = -2.16% × 1.42
2024/06/30 -3.32% = -2.43% × 1.36
2024/03/31 21.67% = 16.81% × 1.29
2023/12/31 20.59% = 15.92% × 1.29
2023/09/30 21.01% = 15.97% × 1.32
2023/06/30 21.75% = 16.54% × 1.32
2023/03/31 22.59% = 17.18% × 1.31
2022/12/31 23.88% = 18.30% × 1.30
2022/09/30 25.12% = 19.59% × 1.28
2022/06/30 26.77% = 20.50% × 1.31
2022/03/31 22.47% = 17.19% × 1.31
2021/12/31 23.19% = 17.44% × 1.33
2021/09/30 22.83% = 17.25% × 1.32
2021/06/30 21.66% = 16.30% × 1.33
2021/03/31 30.76% = 22.80% × 1.35
2020/12/31 31.22% = 23.07% × 1.35
2020/09/30 — = — × 1.39
2020/06/30 — = — × 1.36
2020/03/31 — = — × 1.38

レポートに基づく: 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

ROEを3つの要素に分解

Vertex Pharmaceuticals Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 純利益率 × 資産回転率 × 財務レバレッジ比率
2024/12/31 -3.26% = -4.86% × 0.49 × 1.37
2024/09/30 -3.07% = -4.52% × 0.48 × 1.42
2024/06/30 -3.32% = -4.74% × 0.51 × 1.36
2024/03/31 21.67% = 39.46% × 0.43 × 1.29
2023/12/31 20.59% = 36.68% × 0.43 × 1.29
2023/09/30 21.01% = 35.94% × 0.44 × 1.32
2023/06/30 21.75% = 35.40% × 0.47 × 1.32
2023/03/31 22.59% = 35.40% × 0.49 × 1.31
2022/12/31 23.88% = 37.20% × 0.49 × 1.30
2022/09/30 25.12% = 37.62% × 0.52 × 1.28
2022/06/30 26.77% = 38.26% × 0.54 × 1.31
2022/03/31 22.47% = 30.84% × 0.56 × 1.31
2021/12/31 23.19% = 30.92% × 0.56 × 1.33
2021/09/30 22.83% = 30.52% × 0.57 × 1.32
2021/06/30 21.66% = 29.80% × 0.55 × 1.33
2021/03/31 30.76% = 43.06% × 0.53 × 1.35
2020/12/31 31.22% = 43.70% × 0.53 × 1.35
2020/09/30 — = — × — × 1.39
2020/06/30 — = — × — × 1.36
2020/03/31 — = — × — × 1.38

レポートに基づく: 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

ROEを5つの要素に分解

Vertex Pharmaceuticals Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 税負担 × 利息負担 × EBITマージン × 資産回転率 × 財務レバレッジ比率
2024/12/31 -3.26% = -2.16 × 0.89 × 2.53% × 0.49 × 1.37
2024/09/30 -3.07% = -1.85 × 0.87 × 2.80% × 0.48 × 1.42
2024/06/30 -3.32% = -2.28 × 0.84 × 2.48% × 0.51 × 1.36
2024/03/31 21.67% = 0.84 × 0.99 × 47.23% × 0.43 × 1.29
2023/12/31 20.59% = 0.83 × 0.99 × 44.83% × 0.43 × 1.29
2023/09/30 21.01% = 0.81 × 0.99 × 45.10% × 0.44 × 1.32
2023/06/30 21.75% = 0.78 × 0.99 × 45.81% × 0.47 × 1.32
2023/03/31 22.59% = 0.78 × 0.99 × 45.83% × 0.49 × 1.31
2022/12/31 23.88% = 0.78 × 0.99 × 48.01% × 0.49 × 1.30
2022/09/30 25.12% = 0.81 × 0.99 × 46.95% × 0.52 × 1.28
2022/06/30 26.77% = 0.81 × 0.99 × 47.81% × 0.54 × 1.31
2022/03/31 22.47% = 0.86 × 0.98 × 36.80% × 0.56 × 1.31
2021/12/31 23.19% = 0.86 × 0.98 × 36.86% × 0.56 × 1.33
2021/09/30 22.83% = 0.79 × 0.98 × 39.42% × 0.57 × 1.32
2021/06/30 21.66% = 0.83 × 0.98 × 36.99% × 0.55 × 1.33
2021/03/31 30.76% = 0.84 × 0.98 × 52.07% × 0.53 × 1.35
2020/12/31 31.22% = 0.87 × 0.98 × 51.16% × 0.53 × 1.35
2020/09/30 — = — × — × — × — × 1.39
2020/06/30 — = — × — × — × — × 1.36
2020/03/31 — = — × — × — × — × 1.38

レポートに基づく: 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

ROAを2つのコンポーネントに分解

Vertex Pharmaceuticals Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 純利益率 × 資産回転率
2024/12/31 -2.38% = -4.86% × 0.49
2024/09/30 -2.16% = -4.52% × 0.48
2024/06/30 -2.43% = -4.74% × 0.51
2024/03/31 16.81% = 39.46% × 0.43
2023/12/31 15.92% = 36.68% × 0.43
2023/09/30 15.97% = 35.94% × 0.44
2023/06/30 16.54% = 35.40% × 0.47
2023/03/31 17.18% = 35.40% × 0.49
2022/12/31 18.30% = 37.20% × 0.49
2022/09/30 19.59% = 37.62% × 0.52
2022/06/30 20.50% = 38.26% × 0.54
2022/03/31 17.19% = 30.84% × 0.56
2021/12/31 17.44% = 30.92% × 0.56
2021/09/30 17.25% = 30.52% × 0.57
2021/06/30 16.30% = 29.80% × 0.55
2021/03/31 22.80% = 43.06% × 0.53
2020/12/31 23.07% = 43.70% × 0.53
2020/09/30 — = — × —
2020/06/30 — = — × —
2020/03/31 — = — × —

レポートに基づく: 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

ROAを4つの要素に分解

Vertex Pharmaceuticals Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 税負担 × 利息負担 × EBITマージン × 資産回転率
2024/12/31 -2.38% = -2.16 × 0.89 × 2.53% × 0.49
2024/09/30 -2.16% = -1.85 × 0.87 × 2.80% × 0.48
2024/06/30 -2.43% = -2.28 × 0.84 × 2.48% × 0.51
2024/03/31 16.81% = 0.84 × 0.99 × 47.23% × 0.43
2023/12/31 15.92% = 0.83 × 0.99 × 44.83% × 0.43
2023/09/30 15.97% = 0.81 × 0.99 × 45.10% × 0.44
2023/06/30 16.54% = 0.78 × 0.99 × 45.81% × 0.47
2023/03/31 17.18% = 0.78 × 0.99 × 45.83% × 0.49
2022/12/31 18.30% = 0.78 × 0.99 × 48.01% × 0.49
2022/09/30 19.59% = 0.81 × 0.99 × 46.95% × 0.52
2022/06/30 20.50% = 0.81 × 0.99 × 47.81% × 0.54
2022/03/31 17.19% = 0.86 × 0.98 × 36.80% × 0.56
2021/12/31 17.44% = 0.86 × 0.98 × 36.86% × 0.56
2021/09/30 17.25% = 0.79 × 0.98 × 39.42% × 0.57
2021/06/30 16.30% = 0.83 × 0.98 × 36.99% × 0.55
2021/03/31 22.80% = 0.84 × 0.98 × 52.07% × 0.53
2020/12/31 23.07% = 0.87 × 0.98 × 51.16% × 0.53
2020/09/30 — = — × — × — × —
2020/06/30 — = — × — × — × —
2020/03/31 — = — × — × — × —

レポートに基づく: 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).

当期純利益率の分解

Vertex Pharmaceuticals Inc.、純利益率の分解(四半期データ)

Microsoft Excel
純利益率 = 税負担 × 利息負担 × EBITマージン
2024/12/31 -4.86% = -2.16 × 0.89 × 2.53%
2024/09/30 -4.52% = -1.85 × 0.87 × 2.80%
2024/06/30 -4.74% = -2.28 × 0.84 × 2.48%
2024/03/31 39.46% = 0.84 × 0.99 × 47.23%
2023/12/31 36.68% = 0.83 × 0.99 × 44.83%
2023/09/30 35.94% = 0.81 × 0.99 × 45.10%
2023/06/30 35.40% = 0.78 × 0.99 × 45.81%
2023/03/31 35.40% = 0.78 × 0.99 × 45.83%
2022/12/31 37.20% = 0.78 × 0.99 × 48.01%
2022/09/30 37.62% = 0.81 × 0.99 × 46.95%
2022/06/30 38.26% = 0.81 × 0.99 × 47.81%
2022/03/31 30.84% = 0.86 × 0.98 × 36.80%
2021/12/31 30.92% = 0.86 × 0.98 × 36.86%
2021/09/30 30.52% = 0.79 × 0.98 × 39.42%
2021/06/30 29.80% = 0.83 × 0.98 × 36.99%
2021/03/31 43.06% = 0.84 × 0.98 × 52.07%
2020/12/31 43.70% = 0.87 × 0.98 × 51.16%
2020/09/30 — = — × — × —
2020/06/30 — = — × — × —
2020/03/31 — = — × — × —

レポートに基づく: 10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).